{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:01:26Z","timestamp":1782824486406,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.psc.2013.01.004","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T10:27:14Z","timestamp":1364293634000},"page":"65-72","source":"Crossref","is-referenced-by-count":28,"title":["St. John's Wort for the Treatment of Psychiatric Disorders"],"prefix":"10.1016","volume":"36","author":[{"given":"Jerome","family":"Sarris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.psc.2013.01.004_bib1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1089\/acm.2009.0066","article-title":"Kava and St John's wort: current evidence for use in mood and anxiety disorders","volume":"15","author":"Sarris","year":"2009","journal-title":"J\u00a0Altern Complement Med"},{"issue":"14","key":"10.1016\/j.psc.2013.01.004_bib2","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1001\/jama.287.14.1807","article-title":"Effect of Hypericum perforatum (St\u00a0John's wort) in major depressive disorder: a randomized controlled trial","volume":"287","author":"Hypericum Depression Trial Study Group","year":"2002","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.psc.2013.01.004_bib3","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.285.15.1978","article-title":"Effectiveness of St John's wort in major depression: a randomized controlled trial","volume":"285","author":"Shelton","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.psc.2013.01.004_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.psc.2013.01.004_bib5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4088\/JCP.v65n0504","article-title":"How effective is St John's wort? The evidence revisited","volume":"65","author":"Werneke","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2013.01.004_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000448.pub3","article-title":"St John's wort for major depression","author":"Linde","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.psc.2013.01.004_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pnpbp.2008.10.018","article-title":"Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis","volume":"33","author":"Rahimi","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2013.01.004_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1055\/s-2005-837807","article-title":"Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline","volume":"38","author":"Gastpar","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"11","key":"10.1016\/j.psc.2013.01.004_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.euroneuro.2008.06.006","article-title":"Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression\u2014a double-blind, randomized, placebo controlled long-term trial","volume":"18","author":"Kasper","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"10.1016\/j.psc.2013.01.004_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0032-1306348","article-title":"St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26 week RCT","volume":"45","author":"Sarris","year":"2012","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.psc.2013.01.004_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1185\/03007999909115171","article-title":"Hypericum in seasonal affective disorder (SAD)","volume":"15","author":"Wheatley","year":"1999","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 1","key":"10.1016\/j.psc.2013.01.004_bib12","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1177\/089198879400700109","article-title":"Hypericum in the treatment of seasonal affective disorders","volume":"7","author":"Martinez","year":"1994","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"issue":"8","key":"10.1016\/j.psc.2013.01.004_bib13","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/01.CHI.0000046900.27264.2A","article-title":"An open-label pilot study of St. John's wort in juvenile depression","volume":"42","author":"Findling","year":"2003","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2013.01.004_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/cap.2005.15.293","article-title":"Open-label pilot study of St. John's wort in adolescent depression","volume":"15","author":"Simeon","year":"2005","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"7490","key":"10.1016\/j.psc.2013.01.004_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/bmj.38356.655266.82","article-title":"Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine","volume":"330","author":"Szegedi","year":"2005","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.psc.2013.01.004_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4088\/JCP.v61n0806","article-title":"An open-label trial of St. John's Wort (Hypericum perforatum) in obsessive-compulsive disorder","volume":"61","author":"Taylor","year":"2000","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.psc.2013.01.004_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00004850-200511000-00003","article-title":"St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study","volume":"20","author":"Kobak","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.psc.2013.01.004_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.jcp.0000150227.61501.00","article-title":"St. John's wort versus placebo in social phobia: results from a placebo-controlled pilot study","volume":"25","author":"Kobak","year":"2005","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.psc.2013.01.004_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00213-002-1171-6","article-title":"St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial","volume":"164","author":"Volz","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.psc.2013.01.004_bib20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.psy.0000128900.13711.5b","article-title":"Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial","volume":"66","author":"Muller","year":"2004","journal-title":"Psychosom Med"},{"issue":"22","key":"10.1016\/j.psc.2013.01.004_bib21","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1001\/jama.299.22.2633","article-title":"Hypericum perforatum (St John's Wort) for attention-deficit\/hyperactivity disorder in children and adolescents: a randomized controlled trial","volume":"299","author":"Weber","year":"2008","journal-title":"JAMA"},{"issue":"13\u201314","key":"10.1016\/j.psc.2013.01.004_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s10354-007-0440-8","article-title":"St. John's wort: role of active compounds for its mechanism of action and efficacy","volume":"157","author":"Butterweck","year":"2007","journal-title":"Wien Med Wochenschr"},{"issue":"8","key":"10.1016\/j.psc.2013.01.004_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00023210-200317080-00001","article-title":"Mechanism of action of St John's wort in depression: what is known?","volume":"17","author":"Butterweck","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psc.2013.01.004_bib24","series-title":"St John's wort","author":"Cott","year":"2010"},{"issue":"4","key":"10.1016\/j.psc.2013.01.004_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00213-010-2032-3","article-title":"Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine","volume":"213","author":"Jungke","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.psc.2013.01.004_bib26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0269881108091075","article-title":"A\u00a0proteomic investigation of similarities between conventional and herbal antidepressant treatments","volume":"23","author":"Pennington","year":"2009","journal-title":"J\u00a0Psychopharmacol"},{"issue":"3","key":"10.1016\/j.psc.2013.01.004_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.mp.4001470","article-title":"St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response","volume":"9","author":"Wong","year":"2004","journal-title":"Mol Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2013.01.004_bib28","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/mp.2010.98","article-title":"Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment","volume":"16","author":"Molendijk","year":"2011","journal-title":"Mol Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2013.01.004_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5694\/mja11.10751","article-title":"Current challenges in appraising complementary medicine evidence","volume":"196","author":"Sarris","year":"2012","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.psc.2013.01.004_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5414\/CPP42139","article-title":"Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence","volume":"42","author":"Izzo","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.psc.2013.01.004_bib31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2125.2006.02755.x","article-title":"The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials","volume":"62","author":"Whitten","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.psc.2013.01.004_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-2002-19832","article-title":"John's wort (Hypericum perforatum)\u2013is it safe during breastfeeding?","volume":"35","author":"Klier","year":"2002","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.psc.2013.01.004_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.reprotox.2009.02.003","article-title":"Evaluating the safety of St. John's Wort in human pregnancy","volume":"28","author":"Moretti","year":"2009","journal-title":"Reprod Toxicol"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X13000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X13000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T14:54:20Z","timestamp":1539788060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X13000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0193953X13000051"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2013.01.004","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}